<DOC>
	<DOCNO>NCT01649687</DOCNO>
	<brief_summary>The study investigate efficacy safety allogenous transplantation adipose-derived mesenchyma stem cell patient cerebellar ataxia .</brief_summary>
	<brief_title>Treatment Cerebellar Ataxia With Mesenchymal Stem Cells</brief_title>
	<detailed_description />
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<criteria>Patients diagnose spinocerebellar ataxia 3 ( SCA3 ) multiple system atrophycerebellar ( MSAC ) . Subject 's SARA score 10~20 point . Ages 20~70 year . Signed informed consent patient and/or guardian . Subjects enrol cell therapy study within past 30 day . Pregnancy test positive . Subjects deem suitable study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>